Table 1.
Cell type | Ligand/ receptor | Effect of EphA forward signaling on cell-ECM adhesion | Proposed mechanism | Reference |
---|---|---|---|---|
Neurons (dendritic spines) | EphA4/ ephrin-A3 | ⇓ | Activation of SPAR (Rap1 GAP), leading to integrin inactivation (Figure 3) | 115, 17, 135 |
Prostatic carcinoma (PC-3) |
EphA2/ ephrin-A1 | ⇓ |
|
22, 111, 145 |
Vascular smooth muscle cells (VSMCs) | EphA2/ ephrin-A1 | ⇓ | Inhibition of Rac leading to loss of lamellipodia/reduced integrin recruitment to lamellipodia. | 43 |
NIH 3T3 cells |
|
⇑ |
|
24 66 |
Astrocytes | EphA4/ ephrin-A5 | ⇑ |
|
133 |
Langerhans cells | EphA2, EphA4 & EphA/ ephrin-A3 & ephrin-B1 | ⇑ | Integrin activation. | 41 |